MedTrace Logo

a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection（PROFOUND）

NCT06217900 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 16666

Last updated 2024-01-23

No results posted yet for this study

Summary

This study is a multi-center, case-control study aiming at developing and blinded testing machine learning-based multiple cancers early detection model by prospectively collecting blood samples from newly diagnosed cancer patients and individuals without confirmed cancer diagnosis.

Conditions

Sponsors & Collaborators

  • Peking University People's Hospital

    collaborator OTHER

  • Shanghai Weihe Medical Laboratory Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Jun Wang · Peking University People's Hospital

  • Xiaohui Wu · Shanghai Weihe Medical Laboratory Co., Ltd.

Eligibility

Min Age
40 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-28
Primary Completion
2026-10-31
Completion
2027-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06217900 on ClinicalTrials.gov